|
|
|
|
Science Sparks @ ACTREC
|
 13th October 2025 |
Vol. No. 14 ; Issue No.704 |
|
|
Publications
|
|
1. Singh A, Natu A, Anthony F, Muthu H, Khade B, Smoot DT, Ashktorab H, Gupta S (2025). The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells. Clinical Epigenetics.;17(1):168.
2. Vatsa P, Chaudhary B, Kamble A, Waghmare S, Sharma S, Mandoli A (2025).Disrupting microtubule dynamics to rewire apoptosis, differentiation, and EMT programs in oral squamous cell carcinoma through indenamine derivatives. Bioorganic & Medicinal Chemistry.
|
|
|
|
|
|
|
Video of the Week
|
|
| Liquid Biopsy: The Key to Unlocking a New Era of Precision Oncology |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2019, Targeted therapy Ribociclib, added to endocrine therapy improved survival in young women with certain types of breast cancer.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Bacteria hidden inside tumors could help beat cancer.
|
|
Sciencedaily, 07/10/2025
|
|
Scientists have discovered that bacteria living inside tumors can produce a molecule that fights cancer and enhances chemotherapy. The molecule, called 2-methylisocitrate (2-MiCit), was found to make colorectal cancer cells more vulnerable to chemotherapy by damaging...
|
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
